Dr Fabio Almeida's center in Tucson, AZ


his is the first site to open for this interesting clinical trial using both Zytiga (abiraterone) and Xofigo (radium 223).  

All men will receive Zytiga + prednisone.  Some men will receive Xofigo, some will receive placebo instead of Xofigo.

Clinic visits are every 4-weeks for six months during treatment.  


Basic Eligibility Criteria for this trial:

  • Castrate resistant (Testosterone less than 50 w/ rising PSA)

  • 2 or more bone metastases

  • NO lung, liver, or other soft tissue metastases

  • NO previous chemo

  • NO previous Zytiga (abiraterone)

  • NO previous Xofigo or Samarium

  • Little or no cancer pain

  • NO atrial fibrillation, Crohn's disease, or ulcerative colitis


Arizona Molecular Imaging
Tucson, AZ


Elisa Blackwell 602.331.1771


Other locations to follow - View this link at ClinicalTrials.gov **